Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
8.39
-0.10 (-1.18%)
At close: May 19, 2026, 4:00 PM EDT
8.40
+0.01 (0.12%)
After-hours: May 19, 2026, 7:38 PM EDT
Biohaven Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Biohaven stock has a consensus rating of "Buy" and an average price target of $21.76. The average 1-year stock price forecast is 159.36% higher than the current stock price, while the lowest is $9.00 (+7.27%) and the highest is $50 (+495.95%).
Price Target: $21.76 (+159.36%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biohaven stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Hold | 5 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +114.54% | May 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +162.22% | May 5, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $14 → $17 | Strong Buy | Maintains | $14 → $17 | +102.62% | Apr 2, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $15 → $30 | Strong Buy | Maintains | $15 → $30 | +257.57% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +19.19% | Mar 4, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
32.29M
EPS This Year
-2.90
from -6.86
EPS Next Year
-2.44
from -2.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 105.0M | ||||||
| Avg | n/a | 32.3M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.37 | -1.65 | ||||||
| Avg | -2.90 | -2.44 | ||||||
| Low | -3.87 | -3.58 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.